Thoratec Starts HeartMate II Study As Centers Apply For New LVAD Payment
Thoratec plans to complete a seven-patient, 30-day trial of the HeartMate II continuous-flow left-ventricular assist device at four U.S. centers by the end of 2003
Thoratec plans to complete a seven-patient, 30-day trial of the HeartMate II continuous-flow left-ventricular assist device at four U.S. centers by the end of 2003